Skip to search formSkip to main contentSkip to account menu

Vitamin K antagonists

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Wir möchten den Autoren des Leserbriefes unsere Standpunkte nochmals verdeutlichen. Verschiedene Subgruppenanalysen haben gezeigt… 
2014
2014
UNLABELLED The incidence of atrial fibrillation (AF) and of thromboembolic complications increases along with age. This is also… 
Review
2014
Review
2014
ZusammenfassungVitamin-K-Antagonisten (VKA) waren jahrzehntelang der Standard in der Schlaganfallprophylaxe bei Vorhofflimmern… 
2014
2014
A recent study found the lower cost to be the result of fewer episodes of major bleeding in patients treated with apixaban. 
2013
2013
Results of trials with new oral anticoagulant drugs and vitamin K antagonists (VKA) might not be directly applicable to Dutch… 
2011
2011
This editorial refers to ‘Patients using vitamin K antagonists show increased levels of coronary calcification: an observational… 
Review
2007
Review
2007
To bridge or not to bridge, that is the question. Perhaps the last “bastion” of unresolved issues in antithrombotic therapy is… 
2006
2006
Thromb Haemost 2006; 95: 922–3 Warfarin and other coumarin derivatives acting as vitamin K antagonists (VKA) are teratogenic and… 
Review
2005
Review
2005
Atrial fibrillation (AF) is a major risk factor for stroke. Recent studies show that treatment strategies which combine control… 
Review
2002
Review
2002
cause of mortality and morbidity worldwide, and intensive research over the past few decades has resulted in great progress in…